Tirzepatide Clinical Trials
62 recruitingDrug
Phase 226Phase 416Phase 38Phase 17Early Phase 14Not Applicable4
Showing 1–20 of 62 trials
Recruiting
Phase 2Phase 3
A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
Type 1 DiabetesType 1 Diabetes MellitusT1D+2 more
McGill University Health Centre/Research Institute of the McGill University Health Centre105 enrolled4 locationsNCT07284511
Recruiting
Phase 1
Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)
Alcohol Use Disorder (AUD)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)176 enrolled1 locationNCT07559500
Recruiting
Phase 2
Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV
Obesity and OverweightHIVChronic Inflammation
University of Hawaii12 enrolled1 locationNCT06935838
Recruiting
Phase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company4,500 enrolled562 locationsNCT07165028
Recruiting
Phase 3
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Crohn's DiseaseObesity or Overweight
Eli Lilly and Company290 enrolled187 locationsNCT06937099
Recruiting
Phase 2
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
Opioid-use DisorderOpioid Use Disorder, ModerateOpioid Use Disorder, Severe
T. John Winhusen, PhD310 enrolled9 locationsNCT06651177
Recruiting
Phase 3
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
ObesityWeight Gain
Eli Lilly and Company300 enrolled73 locationsNCT06439277
Recruiting
Phase 2
Multi-Site Trial of Tirzepatide for Smoking Cessation
Smoking CessationSmoking Behaviors
University of Southern California300 enrolled4 locationsNCT07602699
Recruiting
Phase 4
A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity
ObesityDiabetes Mellitus, Type 2Overweight
Eli Lilly and Company344 enrolled21 locationsNCT07438444
Recruiting
Phase 4
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
PsoriasisOverweight or Obesity
Eli Lilly and Company200 enrolled41 locationsNCT06857942
Recruiting
Phase 1Phase 2
A Study to Evaluate ALN-2232 in Participants With Obesity
Obesity
Alnylam Pharmaceuticals156 enrolled1 locationNCT07463846
Recruiting
Phase 3
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Ulcerative ColitisObesity or Overweight
Eli Lilly and Company350 enrolled190 locationsNCT06937086
Recruiting
Phase 2
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
ObesityOverweight
Eli Lilly and Company1,481 enrolled53 locationsNCT06143956
Recruiting
Not Applicable
Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
Obesity, OverweightPsoriatic Arthritis (PsA)
NHS Greater Glasgow and Clyde45 enrolled4 locationsNCT07443956
Recruiting
Early Phase 1
Tirzepatide in Obesity-Driven Endometrial Cancer
Endometrial CancerObesity
UNC Lineberger Comprehensive Cancer Center20 enrolled1 locationNCT07065552
Recruiting
Phase 2
Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
ObesityAcute Lymphoblastic Leukemia
St. Jude Children's Research Hospital20 enrolled1 locationNCT07228741
Recruiting
Phase 1Phase 2
A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Obesity
Arrowhead Pharmaceuticals180 enrolled3 locationsNCT06700538
Recruiting
Phase 4
A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)
Obesity
Eli Lilly and Company3,000 enrolled30 locationsNCT07247084
Recruiting
Phase 1
A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus
ObesityDiabetes Mellitus, Type 2Overweight
Eli Lilly and Company40 enrolled1 locationNCT07299084
Recruiting
Phase 4
Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
Diabetes Mellitus, Type 2DiabetesType 2 Diabetes+1 more
Stanford University104 enrolled2 locationsNCT06657209